Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2010; 16(42): 5334-5341
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5334
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5334
Figure 7 Changes in percentage inhibition resulting from pre- or post-treatment with MK615.
A: Cells were cultured for 24 h with MK615, and then advanced glycation end-products (AGEs) were added, followed by culture for a further 24 h. The proliferative effect of Glycer-AGE was abrogated by pretreatment with MK615 in both HuH7 and HepG2 cells; B: Cells were cultured for 24 h with AGEs, and then MK615 were added, followed by culture for a further 24 h. The proliferative effect elicited by Glycer-AGE was still evident, but was reduced. ss: Statistically significant.
- Citation: Sakuraoka Y, Sawada T, Okada T, Shiraki T, Miura Y, Hiraishi K, Ohsawa T, Adachi M, Takino JI, Takeuchi M, Kubota K. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells. World J Gastroenterol 2010; 16(42): 5334-5341
- URL: https://www.wjgnet.com/1007-9327/full/v16/i42/5334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i42.5334